PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Trane Technologies (TT) gains from transformation initiatives, growth in the HVAC deals, and strength across bookings.

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Progressive (PGR) is poised to grow from its compelling portfolio, leadership position, strength in Vehicle and Property businesses, healthy policies...

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Xylem (XYL) benefits from strength in the businesses and the acquisition of Evoqua. Its measures to reward shareholders are also encouraging.

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.